Evidence map›Paper›PMID 21795602›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

EspR, a key regulator of Mycobacterium tuberculosis virulence, adopts a unique dimeric structure among helix-turn-helix proteins.

Oren S Rosenberg, Cole Dovey, Michael Tempesta, Rebecca A Robbins, Janet S Finer-Moore, Robert M Stroud, Jeffery S Cox

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Adaptation ofmSphere · 2026
    Article
  2. Review
  3. Loss of the ESX-5 secretion locus inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Genome-wide screen identifies host loci that modulatebioRxiv : the preprint server for biology · 2023
    Article
  7. Frontiers in immunology · 2023
    Article
  8. Review
  9. Modeling Tubercular ESX-1 Secretion Using Mycobacterium marinum.Microbiology and molecular biology reviews : MMBR · 2020
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. WithdrawnInfectious disorders drug targets · 2012
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Oren S RosenbergDepartment of Microbiology and Immunology, Program in Microbial Pathogenesis and Host Defense, University of California, San Francisco, CA 94158, USA.
Cole Dovey
Michael Tempesta
Rebecca A Robbins
Janet S Finer-Moore
Robert M Stroud
Jeffery S Cox
University of California, San Francisco · USOffice of Infectious Diseases · US

Funding

BIOLOGY OF INFECTIOUS DISEASES TRAINING PROGRAMT32AI007641 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY · 2000 to 2026
$6.9M
Secretion of Virulence Factors by Mycobacterium tuberculosisR01AI051667 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COX, JEFFERY S · 2001 to 2010
$3.9M
TRNA METHYLASE AND TRNA PSEUDOURIDINE SYNTHASER01GM051232 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STROUD, ROBERT M · 1996 to 2012
$3.4M
Regulation of ESX-1 secretion and its role in M. tuberculosis virulenceR01AI081727 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COX, JEFFERY S · 2010 to 2014
$2.0M
Structural and functional studies of M. tuberculosis type VII secretionK08AI091656 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSENBERG, OREN S · 2011 to 2014
$516k
Regulation of ESX-1 secretion and its role in M. tuberculosis virulenceR56AI081727 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COX, JEFFERY S · 2009 to 2009
$355k
NIAID NIH HHS AI051667NIAID NIH HHS AI081727NIAID NIH HHS K08 AI091656NIAID NIH HHS R01 AI051667NIAID NIH HHS R01 AI081727NIAID NIH HHS R56 AI081727NIAID NIH HHS T32 AI007641NIGMS NIH HHS GM051232NIGMS NIH HHS R01 GM051232
6 · The paper itself

Abstract

EspR is a transcriptional regulator that activates the ESX-1 secretion system during Mycobacterium tuberculosis infection and is critical for pathogenesis. It is unique among DNA-binding proteins as it is secreted as part of a feedback regulatory loop that serves to mitigate transcriptional activity. Here we report the crystal structure of a functional EspR dimer at 2.5-Å resolution. The amino-terminal half of EspR is a helix-turn-helix (HTH) DNA-binding domain and the carboxy terminus consists of a dimerization domain with similarity to the SinR:SinI sporulation regulator of Bacillus subtilis. Surprisingly, the HTH domains of EspR are arranged in an unusual conformation in which they are splayed at an oblique angle to each other, suggesting that EspR binds DNA in a profoundly different way than most other known HTH regulators. By mapping the EspR binding sites in the espACD promoter, using both in vivo and in vitro binding assays, we show that the EspR operators are located unusually far from the promoter. The EspR dimer binds to these sites cooperatively, but the two "half-sites" contacted by each DNA recognition motif are separated by 177 base pairs. The distinctive structure of EspR and the exceptional arrangement of its operator contacts suggest that it could promote DNA looping in its target promoter. We hypothesize that direct DNA looping mediated by single-site binding of each EspR monomer may facilitate transcriptional control of this important virulence system.

Indexed as

Helix-Turn-Helix MotifsProtein Structure, QuaternaryBacterial ProteinsBinding SitesCrystallography, X-RayDNADNA-Binding ProteinsModels, MolecularMycobacterium tuberculosisNucleic Acid ConformationPromoter Regions, GeneticProtein MultimerizationTranscription FactorsVirulenceBacterial ProteinsDNADNA-Binding ProteinsTranscription Factors

Identifiers

PMID21795602
PMCPMC3158157
OpenAlexW1997021926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.